Prostatis Group’s Vanguard FTSE All-World ex-US ETF VEU Stock Holding History

Prostatis Group’s Portfolio VEU Stock Details VEU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$351K	Sell	4,679 -974	-17%	-$75.5K	0.09%	124
2025 Q4	$416K	Buy	5,653 +945	+20%	+$68.7K	0.1%	113
2025 Q3	$336K	Buy	4,708 +305	+7%	+$21.1K	0.08%	117
2025 Q2	$296K	Buy	+4,403	New	+$279K	0.08%	118
2024 Q3	–	Sell	-13,193	Closed	-$774K	–	153
2024 Q2	$774K	Sell	13,193 -495	-4%	-$29K	0.27%	77
2024 Q1	$803K	Buy	+13,688	New	+$774K	0.3%	75
2023 Q1	–	Sell	-9,471	Closed	-$475K	–	113
2022 Q4	$475K	Buy	+9,471	New	+$460K	0.29%	63

Other funds holding VEU

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

FMWA

Forvis Mazars Wealth Advisors Springfield, Missouri $5.27B AUM 18.06% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Prostatis Group's VEU Position: Q1 2026 in Review

Prostatis Group reduced its Vanguard FTSE All-World ex-US ETF (VEU) stake by 17% in Q1 2026, selling an estimated $75.5K and leaving 4,679 shares worth $351K. The position accounts for 0.09% of the portfolio, ranked #124.

Prostatis Group first reported a position in VEU in Q4 2022 and has held it in 7 quarters since. The position peaked at $803K in Q1 2024. 1,559 funds tracked by Wall St. Rank hold VEU as of Q1 2026.

Prostatis Group held 4,679 shares of Vanguard FTSE All-World ex-US ETF worth $351K as of Q1 2026.
Prostatis Group sold 974 Vanguard FTSE All-World ex-US ETF shares in Q1 2026, an estimated $75.5K.
Vanguard FTSE All-World ex-US ETF made up 0.09% of Prostatis Group's portfolio in Q1 2026, its #124 holding.
Prostatis Group first reported a position in Vanguard FTSE All-World ex-US ETF in Q4 2022 and has held it in 7 quarters since.
Prostatis Group's Vanguard FTSE All-World ex-US ETF position peaked at $803K in Q1 2024.
1,559 funds tracked by Wall St. Rank held Vanguard FTSE All-World ex-US ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.